EP3774871
OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.4.2019EP published:
28.6.2023EP application number:
19721447.1
EPO information:
European Patent Register
Max expiry date:
10.4.2039
Title in English:
OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENELanguage of the patent:
English
Timeline
Today
11.4.2019EP application
28.6.2023EP Publication
Owner
Name:
Precision BioSciences, Inc.Address:
302 East Pettigrew Street Dibrell Building, Suite A-100, Durham, NC 27701, US
Inventor
Name:
SMITH, James, JeffersonAddress:
Morrisville, NC 27560, US
Name:
LAPE, JanelAddress:
Wake Forest, NC 27587, US
Name:
LI, HuiAddress:
Apex, NC 27502, US
Name:
GENSCHEL, JochenAddress:
Raleigh, NC 27613, US
Priority
Number:
201862656809 PDate:
12.4.2018Country:
US
Classification
Categories:
C07K 14/725, A61K 38/46, A61K 35/17, C12N 5/0783, C12N 9/22, A61K 35/76, A61K 39/00